Our Business

    We are a globally emerging specialty pharmaceutical company, with a growing presence in India. All our manufacturing processes adhere to GMP guidelines to ensure better quality standards. We emphasise on regulatory compliance that enhances our product quality.

    More Info

    Our Strategy and Core Values

    With a drive for excellence and a value driven strategy, our mission is to improve and upsurge patient survival rate and ensure a high quality of life. Our core values are built on the concepts of Patient-Focused Excellence, Valuing People, Innovation and Delivering Value and Excellence

    More Info

    Our Innovation

    Our innovation focuses on three essential therapeutic focus areas: Oncology, Nephrology Hepatology. Atisa adopts focused portfolio strategies that target these disease areas with the likelihood of successfully developing first-in-class and best-in-class products.

    More Info

    Our Products

    We provide high-quality, affordable medicines to patients. The quest for quality is in our DNA to adopt stringent WHO GMP manufacturing processes to reach globally in specialty segment. In this direction, our global pharmaceuticals portfolio spans multiple therapy areas, including Oncology, Nephrology and Hepatology.

    More Info

    Our Science

    Our R&D dedicated team has strong imprint and objective to accelerate improve pharmaceutical research & Newer scientific approach for its drugs development by collaborating and S&A to share experiences and insights to optimize capabilities, promote standards and develop best practices for better outcome.

    More Info
    Previous Next

    Therapy Areas

    Solid Tumors

    There were an estimated 18 million cancer cases around the world in 2018, of these 9.5 million cases were in men and 8.5 million in women. With this growing global burden...

    More Info

    Haematological Cancer

    Blood cancers, or hematologic cancers, affect the production and function of blood cells. Most of these cancers start in the bone marrow where blood is produced....

    More Info

    Supportive Care

    Supportive care, also called Palliative care, is aimed at relieving suffering and improving quality of life. It is designed to improve quality of life for both the patient and the family....

    More Info

    Our Products

    • All
    • Solid Tumors
    • Haematological
    • Supportive Care

    Futran

    Fulvestrant Inj

    250mg PFS

    Tidar

    Temozolomide Inj

    100mg vial

    Peglip

    Pegylated Liposomal Doxorubicin Inj

    20mg/50mg vial

    Tylap

    Lapatanib

    250mg tablets

    Cadovel

    Bortezomib Inj

    2mg/3.5mg vial

    Zyterone

    Abiraterone Acetate

    250mg tablets

    Nuproline

    Leuprolide Acetate Inj

    3.75mg/11.25mg vial

    Armust

    Carmustine Inj

    100mg vial

    Eenib

    Erlotinib hydrochloride

    150mg tablets

    Lenodo

    Lenalidomide

    5mg/10mg/25mg capsules

    Novotere-rtu

    Docetaxel Inj

    20mg/80mg/120mg vials

    Elodex

    Capecitabine

    250mg tablets

    Eromus

    Everolimus

    5mg/10mg tablets

    Gluto

    L-Glutamine

    15g sachet

    Dexita

    Dexamethasone Inj /tablets

    4mg/8mg tablets; 100mg Inj

    Ketoz

    20g sachet

    Our Team

    Our leadership and Management team remains true to our values, strategy and approach putting patient's evolving needs at the centre of our innovation and holding up belief and expediency as the trademarks of our business.

    S.Somu

    Founder & CEO

    Dr TN Srinivasan

    Consultant and Hon.Director

    Contact Us

    Address

    Atisa Lifesciences Pvt Ltd
    Zareena Plaza, Plot no.A24,
    Journalist Colony, Road No.70,
    Jubilee Hills,Hyderabad-500033,
    Telangana, India

    Phone Number

    040-27145588

    Email

    info@atisalifesciences.com

    Your message has been sent. Thank you!